Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05276973
Title Testing the Addition of Ipatasertib to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) for Stage III or IV Epithelial Ovarian Cancer
Recruitment Recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

endometrial adenocarcinoma

ovarian cancer

peritoneum cancer

fallopian tube cancer

Therapies

Carboplatin + Ipatasertib + Paclitaxel

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.